ONWARD MEDICAL BV EO -12

Research ONWARD MEDICAL BV EO -12 (63E) on Bullrun: market cap EUR 180.77M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker63E
• ExchangeF
• CountryNetherlands
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 180.77M
• Financial periodFY2025
• RevenueEUR 3.78M
• Revenue growth1550.7%
• Net income-EUR 41.79M
• Free cash flow-EUR 39.50M
• Gross margin72.5%

Valuation Snapshot

latest market cap is EUR 180.77M.

About ONWARD MEDICAL BV EO -12

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies;

Frequently asked questions

What is ONWARD MEDICAL BV EO -12's market cap?

ONWARD MEDICAL BV EO -12's market capitalization is EUR 180.77M.

What does ONWARD MEDICAL BV EO -12 do?

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally.